Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
779.71B | 486.51B | 560.19B | 416.90B | 312.79B | Gross Profit |
445.08B | 246.03B | 319.06B | 235.91B | 168.29B | EBIT |
249.69B | 87.07B | 167.69B | 114.73B | 70.73B | EBITDA |
257.13B | 116.73B | 189.08B | 129.70B | 81.56B | Net Income Common Stockholders |
161.18B | 62.29B | 130.40B | 87.30B | 69.79B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
262.54B | 106.70B | 85.54B | 116.58B | 149.16B | Total Assets |
854.21B | 671.23B | 600.22B | 494.70B | 422.64B | Total Debt |
93.50B | 94.44B | 50.84B | 113.81B | 11.85B | Net Debt |
-169.04B | -12.26B | -34.69B | -2.77B | -137.31B | Total Liabilities |
347.67B | 240.05B | 231.53B | 200.07B | 142.27B | Stockholders Equity |
506.54B | 431.18B | 368.69B | 294.62B | 280.37B |
Cash Flow | Free Cash Flow | |||
268.56B | 12.13B | 46.64B | 60.67B | 54.55B | Operating Cash Flow |
285.97B | 32.67B | 70.22B | 78.89B | 67.83B | Investing Cash Flow |
-42.19B | -27.94B | -26.71B | -46.91B | -16.83B | Financing Cash Flow |
-82.82B | 10.76B | -77.43B | -68.74B | -30.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
84 Outperform | $1.31T | 18.65 | 44.53% | 1.74% | -2.37% | 4.89% | |
82 Outperform | $5.85T | 36.26 | 34.01% | 0.47% | 60.27% | 158.92% | |
81 Outperform | $10.95T | 20.00 | 29.69% | 2.50% | 32.83% | 50.73% | |
81 Outperform | $1.05T | 10.57 | 24.78% | 2.69% | 23.84% | 38.09% | |
74 Outperform | $3.40T | 20.72 | 7.22% | 1.40% | -10.70% | -47.63% | |
73 Outperform | $3.48T | 28.08 | 27.22% | 1.22% | 27.88% | 47.09% | |
62 Neutral | $11.80B | 10.31 | -7.45% | 2.91% | 7.43% | -7.78% |